As the aging population increases, the number of patients with osteoporosis is gradually rising. Osteoporosis is a metabolic bone disease characterized by low bone mass and the microarchitectural deterioration of bone tissue, resulting in reduced bone strength and an increased risk of low-energy or fragility fractures. Thus, the use of anti-resorptive agents, such as bisphosphonates (BPs), to prevent osteoporotic fractures is growing annually. BPs are effective in reducing hip and other fractures. However, the longer a patient takes BPs, the higher the risk of an atypical femoral fracture (AFF). The exact mechanism by which long-term BP use affects the development of AFFs has not yet been clarified. However, several theories have been suggested to explain the pathogenesis of AFFs, such as suppressed bone remodeling, impaired bone healing, altered bone quality, and femoral morphology. The management of AFFs requires both medical and surgical approaches. BPs therapy should be discontinued immediately, and calcium and vitamin D levels should be evaluated and supplemented if insufficient. Teriparatide can be used for AFFs. Intramedullary nailing is the primary treatment for complete AFFs, and prophylactic femoral nailing is recommended if signs of an impending fracture are detected.
Background: The Gollop–Wolfgang complex is a rare congenital limb deformity characterized by a bifid femur, tibial hemimelia, and ectrodactyly of the hand. First described in 1980, fewer than 200 cases have been reported globally, with an estimated incidence of 1:1,000,000 live births. Case Presentation: We report a 2-month-old female infant with classic features of the Gollop–Wolfgang complex, including a left bifid femur, complete absence of the left tibia, and contralateral tetradactyly. A clinical examination revealed significant limb length discrepancy, knee instability, equinovarus foot deformity, and skeletal abnormalities confirmed by imaging studies. Extensive investigations, including echocardiography and genetic testing, excluded systemic anomalies and identified non-pathogenic variants in the Collagen Type XI Alpha 2 (COL11A2) and EVC2 genes. A surgical resection of the bifid femur was performed. Results: This case highlights the importance of early diagnosis and a multidisciplinary approach in managing the Gollop–Wolfgang complex. While our case presented with typical features, subtle variations highlight the phenotypic spectrum of the condition. The combination of tibial hemimelia and bifid femur frequently necessitates knee disarticulation due to the absence of a viable tibial anlage, while limb salvage techniques remain challenging. A genetic evaluation identified variants of uncertain significance in the COL11A2 and EVC2 genes, indicating that the genetic basis of the condition is not fully understood. Conclusions: These findings emphasize the need for continued genetic research to clarify the etiology of the Gollop–Wolfgang complex and to improve treatment strategies, particularly in refining surgical approaches and exploring new therapeutic options.
Background/Objectives: Chondromyxoid fibroma (CMF) is a rare benign cartilaginous bone tumor, accounting for less than 1% of all primary bone tumors. Although CMF most commonly arises in the metaphysis of long bones, involvement of the phalanges of the toes is uncommon. We report a pediatric case of CMF arising in the distal phalanx of the second toe that recurred four years after initial surgical treatment and discuss its management. Methods: A 10-year-old girl presented with a painless mass in the distal phalanx of the second toe. Imaging studies demonstrated an expansile osteolytic lesion with cortical thinning, showing a somewhat aggressive radiologic appearance. Intralesional curettage and debridement were performed to preserve the digit, and the bone defect was reconstructed using allogenic cancellous bone graft and demineralized bone matrix. Histopathological examination confirmed the diagnosis of CMF. Results: Four years later, the patient returned with progressive enlargement of the lesion, indicating tumor recurrence. Because of the recurrent nature of the tumor and progressive cosmetic deformity and recurrence-related anxiety, distal phalangectomy was performed. At the one-year follow-up, the patient showed no evidence of recurrence and maintained satisfactory functional and cosmetic outcomes. Conclusions: CMF of the toe phalanx may show delayed recurrence after curettage, requiring prolonged radiologic surveillance. In recurrent cases, definitive resection should be considered based on a combination of oncologic, anatomic, and patient-centered factors, with distal phalangectomy providing reliable local control in anatomically expendable digits.